Literature DB >> 23339473

20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.

Tsuyoshi Ohkura1, Hideki Shiochi, Youhei Fujioka, Keisuke Sumi, Naoya Yamamoto, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroshi Kinoshita, Hiroko Ohkura, Masahiko Kato, Shin-ichi Taniguchi, Kazuhiro Yamamoto.   

Abstract

BACKGROUND: We developed a simple and new insulin resistance index derived from a glucose clamp and a meal tolerance test (MTT) in Japanese patients with type 2 diabetes mellitus.
METHODS: Fifteen patients [mean age: 53 years, fasting plasma glucose (FPG) 7.7 mmol/L, HbA1c 7.1% (54 mmol/mol), body mass index 26.8 kg/m(2)] underwent a MTT and a glucose clamp. Participants were given a test meal (450 kcal). Plasma glucose and insulin were measured at 0 (fasting), 30, 60, 120, and 180 min. Serum C-peptide immunoreactivity (CPR) was measured at 0 (fasting; F-CPR) and 120 min. Homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity indices (ISI) were calculated from the MTT results. The glucose infusion rate (GIR) was measured during hyperinsulinemic-euglycemic glucose clamps.
RESULTS: The mean GIR in all patients was 5.8 mg·kg(-1)·min(-1). The index 20/(F-CPR × FPG) was correlated strongly with GIR (r = 0.83, P < 0.0005). HOMA-IR (r = -0.74, P < 0.005) and ISI (r = 0.66, P < 0.01) were also correlated with GIR. In 10 patients with mild insulin resistance (GIR 5.0-10.0 mg·kg(-1)·min(-1)), 20/(F-CPR × FPG) was very strongly correlated with GIR (r = 0.90, P < 0.0005), but not with HOMA-IR and ISI (r = -0.49, P = 0.15; r = 0.20, P = 0.56, respectively). In patients with mild insulin resistance, plasma adiponectin (r = 0.65, P < 0.05), but not BMI or waist circumstance, was correlated with GIR.
CONCLUSIONS: 20/(F-CPR × FPG) is a simple and effective index of insulin resistance, and performs better than HOMA-IR and ISI in Japanese patients with type 2 diabetes mellitus. Our results suggest that 20/(F-CPR × FPG) is a more effective index than HOMA-IR in Japanese patients with mild insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339473      PMCID: PMC3608161          DOI: 10.1186/1475-2840-12-21

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  29 in total

1.  Statistical evaluation of agreement between two methods for measuring a quantitative variable.

Authors:  J Lee; D Koh; C N Ong
Journal:  Comput Biol Med       Date:  1989       Impact factor: 4.589

2.  Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.

Authors:  K C Chiu; P Cohan; N P Lee; L M Chuang
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

3.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

4.  The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.

Authors:  Christian Anderwald; Marietta Anderwald-Stadler; Miriam Promintzer; Gerhard Prager; Martina Mandl; Peter Nowotny; Martin G Bischof; Michael Wolzt; Bernhard Ludvik; Thomas Kästenbauer; Giovanni Pacini; Anton Luger; Michael Krebs
Journal:  Diabetes Care       Date:  2007-06-26       Impact factor: 19.112

5.  Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects.

Authors:  Fumihiko Sato; Yoshifumi Tamura; Hirotaka Watada; Naoki Kumashiro; Yasuhiro Igarashi; Hiroshi Uchino; Tadayuki Maehara; Shinsuke Kyogoku; Satoshi Sunayama; Hiroyuki Sato; Takahisa Hirose; Yasushi Tanaka; Ryuzo Kawamori
Journal:  J Clin Endocrinol Metab       Date:  2007-05-22       Impact factor: 5.958

6.  Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance.

Authors:  N Yamada; H Yoshinaga; N Sakurai; H Shimano; T Gotoda; Y Ohashi; Y Yazaki; K Kosaka
Journal:  Diabetes Care       Date:  1994-02       Impact factor: 19.112

7.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

Authors:  E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo
Journal:  Diabetes       Date:  1998-10       Impact factor: 9.461

8.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

9.  Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.

Authors:  Minoru Iwata; Shiro Maeda; Yutaka Kamura; Atsuko Takano; Hiromi Kato; Shihou Murakami; Kiyohiro Higuchi; Atsushi Takahashi; Hayato Fujita; Kazuo Hara; Takashi Kadowaki; Kazuyuki Tobe
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

10.  Determinants of intramyocellular lipid accumulation after dietary fat loading in non-obese men.

Authors:  Yuko Sakurai; Yoshifumi Tamura; Kageumi Takeno; Naoki Kumashiro; Fumihiko Sato; Saori Kakehi; Shinichi Ikeda; Yuji Ogura; Norio Saga; Hisashi Naito; Shizuo Katamoto; Yoshio Fujitani; Takahisa Hirose; Ryuzo Kawamori; Hirotaka Watada
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232

View more
  37 in total

1.  Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.

Authors:  Eiji Kutoh; Asuka Wada; Sayaka Terayama
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

Review 2.  Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.

Authors:  Tsuyoshi Ohkura
Journal:  World J Diabetes       Date:  2015-02-15

3.  Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes.

Authors:  David Karasek; Ondrej Krystynik; Dominika Goldmannova; Lubica Cibickova; Jan Schovanek
Journal:  J Appl Biomed       Date:  2020-05-18       Impact factor: 1.797

4.  Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.

Authors:  Tsuyoshi Okura; Yohei Fujioka; Risa Nakamura; Yuichi Ito; Sonoko Kitao; Mari Anno; Kazuhisa Matsumoto; Kyoko Shoji; Hiroko Okura; Kazuhiko Matsuzawa; Shoichiro Izawa; Etsuko Ueta; Masahiko Kato; Takeshi Imamura; Shin-Ichi Taniguchi; Kazuhiro Yamamoto
Journal:  Diabetol Metab Syndr       Date:  2022-06-07       Impact factor: 5.395

5.  Association between sleep disordered breathing in early pregnancy and glucose metabolism.

Authors:  Laura Sanapo; Margaret H Bublitz; Alice Bai; Niharika Mehta; Geralyn M Messerlian; Patrick Catalano; Ghada Bourjeily
Journal:  Sleep       Date:  2022-04-11       Impact factor: 6.313

6.  The Predictive Factors for Diabetic Remission in Chinese Patients with BMI > 30 kg/m2 and BMI < 30 kg/m2 Are Different.

Authors:  Hui Liang; Qing Cao; Huan Liu; Wei Guan; Claudia Wong; Daniel Tong
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

7.  A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.

Authors:  Hung-Tsung Wu; Horng-Yih Ou; Hao-Chang Hung; Yu-Chu Su; Feng-Hwa Lu; Jin-Shang Wu; Yi-Ching Yang; Chao-Liang Wu; Chih-Jen Chang
Journal:  Diabetologia       Date:  2016-05-25       Impact factor: 10.122

8.  Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.

Authors:  Tsuyoshi Ohkura; Youhei Fujioka; Keisuke Sumi; Risa Nakanishi; Hideki Shiochi; Naoya Yamamoto; Kazuhiko Matsuzawa; Shoichiro Izawa; Hiroko Ohkura; Masahiko Kato; Shin-Ichi Taniguchi; Kazuhiro Yamamoto
Journal:  Diabetes Ther       Date:  2014-06-03       Impact factor: 2.945

9.  Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients.

Authors:  Yuriko Matsushita; Yutaka Hasegawa; Noriko Takebe; Ken Onodera; Masaharu Shozushima; Tomoyasu Oda; Kan Nagasawa; Hiroyuki Honma; Koji Nata; Akira Sasaki; Yasushi Ishigaki
Journal:  J Diabetes Investig       Date:  2020-11-12       Impact factor: 4.232

10.  Associations of gestational cardiovascular health with pregnancy outcomes: the Hyperglycemia and Adverse Pregnancy Outcome study.

Authors:  Amanda M Perak; Nicola Lancki; Alan Kuang; Darwin R Labarthe; Norrina B Allen; Svati H Shah; Lynn P Lowe; William A Grobman; Denise M Scholtens; Donald M Lloyd-Jones; William L Lowe
Journal:  Am J Obstet Gynecol       Date:  2020-08-05       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.